Benedikt Stefansson
Contacto de Relaciones con Inversores en ALVOTECH .
Perfil
Benedikt Stefansson is currently working as a Senior Director-IR & Global Communication at Alvotech.
Previously, he held positions as Vice President-Sales & Marketing at deCODE genetics, Inc., Research Analyst at Landsbanki Research, and Head-Business Development at CRI hf.
Mr. Stefansson completed his graduate degree at the University of California, Los Angeles.
Cargos activos de Benedikt Stefansson
| Empresas | Cargo | Inicio |
|---|---|---|
| ALVOTECH | Contacto de Relaciones con Inversores | 02/03/2022 |
Antiguos cargos conocidos de Benedikt Stefansson.
| Empresas | Cargo | Fin |
|---|---|---|
CRI hf.
 CRI hf. Chemicals: SpecialtyProcess Industries CRI hf. captures carbon dioxide from industrial emissions and converts carbon dioxide into renewable methanol. It produces renewable methanol from carbon dioxide, hydrogen and electricity for energy storage, fuel applications and enhancement. The firm serves the following industries: bio diesel production, chemicals, gasoline blending, and wastewater treatment industries. Its services include project partnership, feasibility to investment, project execution, and lifetime operation services. The company was founded by Oddur Ingólfsson, Arthur Shulenberger, Fridrik Jonsson, and K-C Tran in 2006 and is headquartered in Kopavogur, Iceland. | Corporate Officer/Principal | - |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Ventas & Marketing | - |
| Landsbanki Research | Analyst-Equity | - |
Formación de Benedikt Stefansson.
| University of California, Los Angeles | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALVOTECH | Health Technology |
| Empresas privadas | 3 |
|---|---|
| Landsbanki Research | |
CRI hf.
CRI hf. Chemicals: SpecialtyProcess Industries CRI hf. captures carbon dioxide from industrial emissions and converts carbon dioxide into renewable methanol. It produces renewable methanol from carbon dioxide, hydrogen and electricity for energy storage, fuel applications and enhancement. The firm serves the following industries: bio diesel production, chemicals, gasoline blending, and wastewater treatment industries. Its services include project partnership, feasibility to investment, project execution, and lifetime operation services. The company was founded by Oddur Ingólfsson, Arthur Shulenberger, Fridrik Jonsson, and K-C Tran in 2006 and is headquartered in Kopavogur, Iceland. | Process Industries |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Bolsa de valores
- Insiders
- Benedikt Stefansson
